Financhill
Back

Global X NASDAQ 100 Covered Call ETF Vs. Bright Minds Biosciences, Inc. Sector Stock Comparison

Buy
58

QYLD
Global X NASDAQ 100 Covered Call ETF

Last Price:
$17.68
Seasonality Move:
-2.58%
Buy
59

DRUG
Bright Minds Biosciences, Inc.

Last Price:
$83.39
Seasonality Move:
-24.59%
Buy
58
Global X NASDAQ 100 Covered Call ETF (QYLD) is a Buy

Is Global X NASDAQ 100 Covered Call ETF a Buy, Sell or Hold?

  • The current Global X NASDAQ 100 Covered Call ETF [QYLD] share price is $17.67. The Score for QYLD is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • QYLD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
59
Bright Minds Biosciences, Inc. (DRUG) is a Buy

Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?

  • The current Bright Minds Biosciences, Inc. [DRUG] share price is $78.04. The Score for DRUG is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • DRUG is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

QYLD Stock Price Chart

What is Global X NASDAQ 100 Covered Call ETF's stock price today?

  • The Global X NASDAQ 100 Covered Call ETF share price today is $17.67
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and QYLD is experiencing selling pressure, which indicates risk of future bearish movement.

DRUG Stock Price Chart

What is Bright Minds Biosciences, Inc.'s stock price today?

  • The Bright Minds Biosciences, Inc. share price today is $78.04
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight buying pressure.

QYLD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.92 Buy
Relative Strength Index (14 RSI): 58.34 Buy
Chaikin Money Flow: -4961318 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.46 - 17.68) Buy
Bollinger Bands (100): (16.86 - 17.52) Buy

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.39 Buy
Relative Strength Index (14 RSI): 51.06 Buy
Chaikin Money Flow: 3906 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (70.36 - 86.3) Sell
Bollinger Bands (100): (44.73 - 72.77) Buy

QYLD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.7 Sell
20-day SMA: 17.61 Buy
50-day SMA: 17.47 Buy
200-day SMA: 16.85 Buy
8-day EMA: 15.86 Buy
20-day EMA: 10.51 Buy
50-day EMA: 5.35 Buy
200-day EMA: 1.52 Buy

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 80.59 Sell
20-day SMA: 81.3 Sell
50-day SMA: 68.25 Buy
200-day SMA: 44.64 Buy
8-day EMA: 80.24 Sell
20-day EMA: 78.78 Sell
50-day EMA: 70.62 Buy
200-day EMA: 49.86 Buy

Global X NASDAQ 100 Covered Call ETF Earnings Growth & QYLD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.72 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.14 per share, and a decrease next year of $1.09 per share.

Global X NASDAQ 100 Covered Call ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):